Skanska receives $120m contract to build new medical centre in US

Skanska has received a contract worth $120m from NYU Langone Medical Centre to construct a new medical centre in New York City, US.

Free Report

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.

By GlobalData

By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

As part of the deal, Skanska will construct a 15,000ft² five-story ambulatory care centre. It will include an emergency department, surgical and imaging suites, a pharmacy and physician office space.

Pre-construction services of the project have commenced and it is expected to be completed in October 2017.

NYU Langone’s breast surgery division deployed MarginProbe for early stage breast cancer.

"Pre-construction services of the project have commenced and it is expected to be completed in October 2017."

Developed by Dune Medical Devices, MarginProbe uses non-destructive radio-frequency spectroscopy technology in the operating room to analyse outer margins of removed cancerous tissue to detect traces of cancer cells.

The surgeon excises additional tissue from the surgical site to ensure no additional cancer cells remain, if cancer cells are detected along margins of the removed tissue.

NYU Langone Medical Centre breast surgery director Freya Schnabel said: "The greatest benefit of MarginProbe is that we can perform this additional tissue removal during a patient’s initial surgery, thereby sparing them the anxiety and frustration of additional follow-up surgery.

"We found that adjunctive use of the MarginProbe device in the operating room significantly improved surgeons’ ability to identify additional cancer cells on the margins of removed tumors."